Thomson Medical Group Limited, commonly referred to as Thomson Medical, is a leading healthcare provider headquartered in Singapore (SG). Established in 1979, the company has made significant strides in the medical industry, focusing primarily on maternal and child healthcare, as well as a range of specialist medical services. With a commitment to delivering high-quality care, Thomson Medical operates several hospitals and clinics across Singapore, catering to diverse healthcare needs. Its core offerings include obstetrics, gynaecology, paediatrics, and fertility treatments, distinguished by a patient-centric approach and advanced medical technology. Recognised for its excellence, Thomson Medical has garnered numerous accolades, solidifying its position as a trusted name in the healthcare sector. The group's dedication to innovation and quality care continues to set it apart in a competitive market.
How does Thomson Medical Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Thomson Medical Group Limited's score of 20 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Thomson Medical Group Limited reported significant carbon emissions, totalling approximately 234,708,000 kg CO2e. This figure comprises about 225,938,000 kg CO2e from Scope 1 emissions and approximately 8,477,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Despite the substantial emissions, there are currently no specific reduction targets or initiatives outlined in their climate commitments. Thomson Medical Group Limited has not made any pledges or commitments to reduce their carbon footprint, nor have they set targets in line with the Science Based Targets initiative (SBTi). The company’s emissions data reflects its operational impact, and while it has disclosed its Scope 1 and 2 emissions, further transparency regarding Scope 3 emissions and future climate strategies would be beneficial for stakeholders.
Access structured emissions data, company-specific emission factors, and source documents
2024 | |
---|---|
Scope 1 | 225,938,000 |
Scope 2 | 8,477,000 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thomson Medical Group Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.